Ranbaxy Halts Production Of Generic Lipitor
India-based drugmaker Ranbaxy Laboratories Ltd. has halted production of its generic version of cholesterol treatment Lipitor after recalling several dozen batches over concerns that the pills might contain tiny glass fragments,...To view the full article, register now.
Already a subscriber? Click here to view full article